BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2951821)

  • 1. Bronchodilator effect of the association ipratropium bromide plus fenoterol (low doses) versus terbutaline and salbutamol in bronchitic patients.
    Marín J; Servera E; Vergara P; Diaz J; Calpe JL; Pérez D; Garcia Barbal J
    Respiration; 1986; 50 Suppl 2():276-9. PubMed ID: 2951821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose response study comparing Duovent vs salbutamol.
    Stewart DE; Gillies AJ
    N Z Med J; 1987 Dec; 100(837):742-4. PubMed ID: 2967936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the intensity and duration of the bronchodilatory action of fenoterol-ipratropium bromide in combination compared with terbutaline and placebo in patients with chronic obstructive lung disease.
    Longhini E; Bozzoni M; Mastropasqua B; Marazzini L
    Respiration; 1986; 50 Suppl 2():169-72. PubMed ID: 2951799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
    Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
    Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
    Kaik G
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma.
    Flint KC; Hockley B; Johnson NM
    Postgrad Med J; 1983 Nov; 59(697):724-5. PubMed ID: 6227877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol.
    Tang OT; Flatley M
    Postgrad Med J; 1984; 60 Suppl 1():24-7. PubMed ID: 6233547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute on chronic comparative effects of a combination of fenoterol-ipratropium bromide and terbutaline in patients with chronic obstructive lung disease.
    Grassi V; Bruni B; Peccini F; Tantucci C; Todisco T
    Respiration; 1986; 50 Suppl 2():226-31. PubMed ID: 2951811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients.
    Fontana G; Mugnai M; Cresci F; Panuccio P
    Respiration; 1986; 50 Suppl 2():201-5. PubMed ID: 2951806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose comparison of salbutamol and Duovent-Berodual in asthma.
    Crane J
    Respiration; 1986; 50 Suppl 2():285-9. PubMed ID: 2951823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilating and density dependence effects of fenoterol, ipratropium bromide and Duovent in reversible chronic obstructive pulmonary disease.
    Dubois PE; Delwiche JP; Minette P; Lulling J; Prignot J
    Respiration; 1986; 50 Suppl 2():280-4. PubMed ID: 2951822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of a combination of bronchodilators.
    Casali L; Grassi C; Rampulla C; Rossi A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):277-80. PubMed ID: 157338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol versus Duovent (a combination of fenoterol and ipratropium bromide) in asthma.
    Flint K; Hockley B; Johnson NM
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():548-50. PubMed ID: 6225674
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effect of Duovent versus salbutamol in long-term treatment.
    Aquilina R; Bergero F; Noceti P; Mirabelli S; Luciani G
    Respiration; 1986; 50 Suppl 2():240-4. PubMed ID: 2951814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative dose-response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma.
    Grandordy BM; Thomas V; de Lauture D; Marsac J
    Eur Respir J; 1988 Jun; 1(6):531-5. PubMed ID: 2971564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the bronchodilatation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination.
    Shneerson JM
    Respiration; 1986; 50 Suppl 2():274-5. PubMed ID: 2951820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.